📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors (2022)

First Author: Lappin K

Attributed to: Functional characterisation of a novel BRCA1-mRNA splicing complex that is mutated in multiple cancers. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-21-1843

PubMed Identifier: 35027467

Publication URI: http://europepmc.org/abstract/MED/35027467

Type: Journal Article/Review

Parent Publication: Cancer Research

Issue: 5

ISSN: 0008-5472